Search research articles
Contact Us
Filters
Showing results (131-140 of 156) with videos related to
Page
of 16
Sort By:
Msystems
|
September 30, 2020
Depression in Individuals Coinfected with HIV and HCV Is Associated with Systematic Differences in the Gut Microbiome and Metabolome
Bryn C Taylor, Kelly C Weldon, Ronald J Ellis, et al.
Journal of Virology
|
March 30, 2005
Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis
Wilfred E Marissen, R Arjen Kramer, Amy Rice, et al.
Lancet (London, England)
|
May 24, 2016
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial
Edwin J Asturias, Ananda S Bandyopadhyay, Steve Self, et al.
NPJ Vaccines
|
July 30, 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
Rahnuma Wahid, Laina Mercer, Andrew Macadam, et al.
European Journal of Immunology
|
June 23, 2005
The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries
R Arjen Kramer, Wilfred E Marissen, Jaap Goudsmit, et al.
Nature Communications
|
August 15, 2025
Basigin links altered skeletal stem cell lineage dynamics with glucocorticoid-induced bone loss and impaired angiogenesis
Thomas H Ambrosi, David Morales, Kun Chen, et al.
Cell Reports
|
March 22, 2024
Peripheral neuronal activation shapes the microbiome and alters gut physiology
Jessica A Griffiths, Bryan B Yoo, Peter Thuy-Boun, et al.
The Journal of Infectious Diseases
|
October 5, 2021
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials
Christopher Gast, Ananda S Bandyopadhyay, Xavier Sáez-Llorens, et al.
Lancet (London, England)
|
December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
Ilse De Coster, Isabel Leroux-Roels, Ananda S Bandyopadhyay, et al.
Lancet (London, England)
|
June 9, 2019
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study
Pierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 156) with videos related to
Sort By:
Page
of 16
Msystems
|
September 30, 2020
Depression in Individuals Coinfected with HIV and HCV Is Associated with Systematic Differences in the Gut Microbiome and Metabolome
Bryn C Taylor, Kelly C Weldon, Ronald J Ellis, et al.
Journal of Virology
|
March 30, 2005
Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis
Wilfred E Marissen, R Arjen Kramer, Amy Rice, et al.
Lancet (London, England)
|
May 24, 2016
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial
Edwin J Asturias, Ananda S Bandyopadhyay, Steve Self, et al.
NPJ Vaccines
|
July 30, 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
Rahnuma Wahid, Laina Mercer, Andrew Macadam, et al.
European Journal of Immunology
|
June 23, 2005
The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries
R Arjen Kramer, Wilfred E Marissen, Jaap Goudsmit, et al.
Nature Communications
|
August 15, 2025
Basigin links altered skeletal stem cell lineage dynamics with glucocorticoid-induced bone loss and impaired angiogenesis
Thomas H Ambrosi, David Morales, Kun Chen, et al.
Cell Reports
|
March 22, 2024
Peripheral neuronal activation shapes the microbiome and alters gut physiology
Jessica A Griffiths, Bryan B Yoo, Peter Thuy-Boun, et al.
The Journal of Infectious Diseases
|
October 5, 2021
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials
Christopher Gast, Ananda S Bandyopadhyay, Xavier Sáez-Llorens, et al.
Lancet (London, England)
|
December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
Ilse De Coster, Isabel Leroux-Roels, Ananda S Bandyopadhyay, et al.
Lancet (London, England)
|
June 9, 2019
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study
Pierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay, et al.
Page
of 16